Drug Type Oncolytic virus |
Synonyms GCM 101, GCM101 |
Target |
Action inhibitors |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | South Korea | 22 Aug 2024 | |
| Colonic Cancer | Preclinical | South Korea | 22 Aug 2024 | |
| Lung Cancer | Preclinical | South Korea | 22 Aug 2024 | |
| Ovarian Cancer | Preclinical | South Korea | 22 Aug 2024 | |
| Pancreatic Cancer | Preclinical | South Korea | 22 Aug 2024 | |
| Prostatic Cancer | Preclinical | South Korea | 22 Aug 2024 |





